Show simple item record

dc.contributor.authorKotagiri, Prasanti
dc.date.accessioned2022-06-10T12:20:08Z
dc.date.available2022-06-10T12:20:08Z
dc.date.submitted2022-06
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/337984
dc.description.abstractSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) resulting in Coronavirus disease 2019 (COVID-19) was declared by the World Health Organization a global pandemic on March 11, 2020. SARS-CoV-2 primarily infects respiratory epithelial cells, and results in a range of clinical manifestations from asymptomatic disease to multi-organ failure. We studied the immune response of SARS-CoV-2-infected individuals with a range of severities followed over 2- 6 months from symptom onset. We undertook deep immune-phenotyping and transcriptomic analysis. We demonstrated that an early robust immune response, without systemic inflammation, was characteristic of asymptomatic or mild disease. Immune recovery was complex, with profound persistent cellular abnormalities correlating with a change in the nature of the inflammatory response, where signatures characteristic of increased oxidative phosphorylation and reactive-oxygen species-associated inflammation replace those driven by TNF and IL-6. In addition, we performed B cell receptor repertoire analysis of SARS-CoV-2 infected individuals and recipients of SARS-CoV-2 vaccine. B cells play a central role in the immune response to both SARS-CoV-2 infection and vaccination. We found marked differences in the global BCR repertoire after natural infection compared to vaccination. Following infection, the proportion of BCRs bearing IgG1/3 and IgA1 isotypes increased, somatic hypermutation (SHM) was markedly decreased and, in patients with severe disease, expansion of IgM and IgA clones were observed. In contrast, after vaccination the proportion of BCRs bearing IgD/M isotypes increased, SHM was unchanged and expansion of IgG clones was prominent. Infection generated a broad distribution of SARS-CoV-2-specific clones predicted to target the spike protein whilst vaccination produced a more focused response mainly targeting the spike’s receptor-binding domain. These findings offer insights into how different immune exposure to SARS-CoV-2 impacts upon BCR repertoire development, potentially informing vaccine strategies.
dc.description.sponsorshipThe Royal Australasian College of Physicians, Jacquot Research Entry Fellowship
dc.rightsAll Rights Reserved
dc.rights.urihttps://www.rioxx.net/licenses/all-rights-reserved/
dc.subjectSARS-CoV-2
dc.subjectBCR repertoire
dc.subjectTranscriptomics
dc.titleImmune Transcriptome and B cell receptor repertoire in COVID-19
dc.typeThesis
dc.type.qualificationlevelDoctoral
dc.type.qualificationnameDoctor of Philosophy (PhD)
dc.publisher.institutionUniversity of Cambridge
dc.date.updated2022-06-10T07:36:16Z
dc.identifier.doi10.17863/CAM.85391
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/all-rights-reserved/
rioxxterms.typeThesis
cam.supervisorSmith, Ken
cam.supervisorLyons, Paul
cam.depositDate2022-06-10
pubs.licence-identifierapollo-deposit-licence-2-1
pubs.licence-display-nameApollo Repository Deposit Licence Agreement
rioxxterms.freetoread.startdate2023-06-10


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record